VR Adviser, LLC
- SEC CIK
- 0001615982
- Latest filing
- Aug 14, 2026
ELVN holding history
Enliven Therapeutics, Inc. in every 13F filed by VR Adviser, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ELVN overviewAll 13F holders of ELVNFull Q2 2026 holdings
- Shares (Q2 2026)
- 526,331
- Value
- $26.7M
- % of portfolio
- 0.8%
- Quarters held
- 14
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 526,331 | $26.7M | 0.8% | −1,200,000−69.5% | Reduced | Holders |
| Q1 2026 | 1,726,331 | $67.7M | 2.5% | −1,500,000−46.5% | Reduced | Holders |
| Q4 2025 | 3,226,331 | $49.7M | 2.5% | 00.0% | Unchanged | Holders |
| Q3 2025 | 3,226,331 | $66.0M | 3.7% | −800,000−19.9% | Reduced | Holders |
| Q2 2025 | 4,026,331 | $80.8M | 6.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 4,026,331 | $79.2M | 6.7% | 00.0% | Unchanged | Holders |
| Q4 2024 | 4,026,331 | $90.6M | 6.2% | 00.0% | Unchanged | Holders |
| Q3 2024 | 4,026,331 | $102.8M | 5.4% | 00.0% | Unchanged | Holders |
| Q2 2024 | 4,026,331 | $94.1M | 6.0% | 00.0% | Unchanged | Holders |
| Q1 2024 | 4,026,331 | $70.8M | 3.4% | +1,071,429+36.3% | Added | Holders |
| Q4 2023 | 2,954,902 | $40.9M | 2.8% | 00.0% | Unchanged | Holders |
| Q3 2023 | 2,954,902 | $40.4M | 4.2% | +724,775+32.5% | Added | Holders |
| Q2 2023 | 2,230,127 | $45.5M | 7.3% | +15,985+0.7% | Added | Holders |
| Q1 2023 | 2,214,142 | $48.5M | 9.5% | +2,214,142 | New | Holders |